Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer

Ramon T. Li, Sanam Zahedi, Judy Trieu, Alfred Lea, William Calhoun, Alexander Duarte, Jianping Zhao, Ikenna Okereke

Research output: Contribution to journalArticle

Abstract

Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9% and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.

Original languageEnglish (US)
Pages (from-to)E1096-E1099
JournalJournal of Thoracic Disease
Volume9
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Lung Transplantation
Pneumonectomy
Small Cell Lung Carcinoma
Lung Neoplasms
Fibrosis
Transplants
Non-Small Cell Lung Carcinoma
Immunosuppression
Lung Diseases
Transplantation
Smoking
History
Lung
Therapeutics

Keywords

  • Lung transplant
  • Pneumonectomy
  • Small cell lung carcinoma (SCLC)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer. / Li, Ramon T.; Zahedi, Sanam; Trieu, Judy; Lea, Alfred; Calhoun, William; Duarte, Alexander; Zhao, Jianping; Okereke, Ikenna.

In: Journal of Thoracic Disease, Vol. 9, No. 12, 01.12.2017, p. E1096-E1099.

Research output: Contribution to journalArticle

@article{4ff9be48d9a04056b2ed9659028c2793,
title = "Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer",
abstract = "Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9{\%} and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.",
keywords = "Lung transplant, Pneumonectomy, Small cell lung carcinoma (SCLC)",
author = "Li, {Ramon T.} and Sanam Zahedi and Judy Trieu and Alfred Lea and William Calhoun and Alexander Duarte and Jianping Zhao and Ikenna Okereke",
year = "2017",
month = "12",
day = "1",
doi = "10.21037/jtd.2017.10.106",
language = "English (US)",
volume = "9",
pages = "E1096--E1099",
journal = "Journal of Thoracic Disease",
issn = "2072-1439",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "12",

}

TY - JOUR

T1 - Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer

AU - Li, Ramon T.

AU - Zahedi, Sanam

AU - Trieu, Judy

AU - Lea, Alfred

AU - Calhoun, William

AU - Duarte, Alexander

AU - Zhao, Jianping

AU - Okereke, Ikenna

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9% and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.

AB - Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9% and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.

KW - Lung transplant

KW - Pneumonectomy

KW - Small cell lung carcinoma (SCLC)

UR - http://www.scopus.com/inward/record.url?scp=85039775353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039775353&partnerID=8YFLogxK

U2 - 10.21037/jtd.2017.10.106

DO - 10.21037/jtd.2017.10.106

M3 - Article

AN - SCOPUS:85039775353

VL - 9

SP - E1096-E1099

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

SN - 2072-1439

IS - 12

ER -